SCHEMBL7226350

SCHEMBL7226350

O=C(CC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)CCN2

nearest known ligand 0.81

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ACHE P22303 16/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4512070 0.90 ACHE (1.00) ACHE
Fumaric Acid SCHEMBL9200183 0.85 ACHE (0.91) ACHE
Fumaric Acid SCHEMBL9200177 0.85 ACHE (0.91) ACHE
SCHEMBL9201766 0.84 ACHE (1.00) ACHE
SCHEMBL9201840 0.83 ACHE (1.00) ACHE
Hydrochloric Acid SCHEMBL9199392 0.83 ACHE (0.98) ACHE
Hydrochloric Acid SCHEMBL7227658 0.82 ACHE (0.66) ACHE
SCHEMBL1681897 0.80 ACHE (0.64) ACHE
Fumaric Acid SCHEMBL9208284 0.80 ACHE (0.91) ACHE
Fumaric Acid SCHEMBL9208275 0.80 ACHE (0.91) ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6534496-B1 Prophylactic and/or therapeutic drug for obesity and obesity associated diseasestor diabetes with a reduced risk for central side effects and high universality in usage. Another object of the a lipolytic agent, or a prophylactic and/or TAKEDA CHEMICAL INDUSTRIES, INC. (JP) 2003-03-18 US disclosed